Treatment satisfaction in patients with relapsing-remitting multiple sclerosis initiated on teriflunomide in routine clinical practice: Australian observational data

BACKGROUND: Adherence and persistence are critical to optimising therapeutic benefit from disease-modifying therapies (DMTs) in relapsing-remitting multiple sclerosis (RRMS). This prospective, open-label, multicentre, observational study (AubPRO), conducted in 13 hospital-based neurology clinics aro...

Descripción completa

Detalles Bibliográficos
Autores principales: Hardy, Todd A, Parratt, John, Beadnall, Heidi, Blum, Stefan, Macdonell, Richard, Beran, Roy G, Shuey, Neil, Lee, Andrew, Carroll, William, Shaw, Cameron, Worrell, Richard, Moody, Jana, Sedhom, Mamdouh, Barnett, Michael, Vucic, Steve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255404/
https://www.ncbi.nlm.nih.gov/pubmed/35865788
http://dx.doi.org/10.1136/bmjno-2022-000315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255404/
https://www.ncbi.nlm.nih.gov/pubmed/35865788
http://dx.doi.org/10.1136/bmjno-2022-000315

Ejemplares similares